This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1974 Mar 20;21(3):101-6.

Experimental screening of 3 forms and 19 derivatives or analogs of ellipticine: oncostatic effect on l 1210 leukaemia and immunosuppressive effect of 4 of them

M Hayat, G Mathé, M M Janot, P Potier, N Dat-Xuong, A Cavé, T Sevenet, C Kan-Fan, J Poisson, J Miet, J Le Men, F Le Goffic, A Gouyette, A Ahond, L K Dalton, T A Connors

PMID: 4429763

Comparative Study

Experimental screening of 3 forms and 19 derivatives or analogs of ellipticine: oncostatic effect on l 1210 leukaemia and immunosuppressive effect of 4 of them

M Hayat et al. Biomedicine. 1974.

. 1974 Mar 20;21(3):101-6.

Authors

M Hayat, G Mathé, M M Janot, P Potier, N Dat-Xuong, A Cavé, T Sevenet, C Kan-Fan, J Poisson, J Miet, J Le Men, F Le Goffic, A Gouyette, A Ahond, L K Dalton, T A Connors

PMID: 4429763

No abstract available

PubMed Disclaimer

Similar articles

Methoxy-9-ellipticine lactate. I. Experimental study (oncostatic and immunosuppressive actions; preclinical pharmacology).
Le Men J, Hayat M, Mathé G, Guillon JC, Chenu E, Humblot M, Masson Y. Le Men J, et al. Rev Eur Etud Clin Biol. 1970 May;15(5):534-8. Rev Eur Etud Clin Biol. 1970. PMID: 5430156 No abstract available.
A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs.
Le Pecq JB, Nguyen-Dat-Xuong, Gosse C, Paoletti C. Le Pecq JB, et al. Proc Natl Acad Sci U S A. 1974 Dec;71(12):5078-82. doi: 10.1073/pnas.71.12.5078. Proc Natl Acad Sci U S A. 1974. PMID: 4531039 Free PMC article.
Oncostatic effects of Alangium vitiense extracts (ICIG-EORTC 1131, 1186 and 1207) on lymphoid murine tumors.
Mathé G, Hayat M, Chenu E, Husson HP, Thevenet T, Kan C, Potier P. Mathé G, et al. Cancer Res. 1978 May;38(5):1465-7. Cancer Res. 1978. PMID: 580415
Homoharringtonine--perspectives on an active new natural product.
O'Dwyer PJ, King SA, Hoth DF, Suffness M, Leyland-Jones B. O'Dwyer PJ, et al. J Clin Oncol. 1986 Oct;4(10):1563-8. doi: 10.1200/JCO.1986.4.10.1563. J Clin Oncol. 1986. PMID: 3531426 Review. No abstract available.
Taxol. Out of the woods.
Edgington SM. Edgington SM. Biotechnology (N Y). 1991 Oct;9(10):933-8. doi: 10.1038/nbt1091-933. Biotechnology (N Y). 1991. PMID: 1369464 Review. No abstract available.

See all similar articles

Cited by

Histamine-releasing properties of hydroxy-9-methyl-2-ellipticinium acetate.
Eschalier A, Advenier C, Lebel B, Burtin C, Lavarenne J. Eschalier A, et al. Cancer Chemother Pharmacol. 1981;5(4):233-6. doi: 10.1007/BF00434390. Cancer Chemother Pharmacol. 1981. PMID: 6167376
New cancer chemotherapy drugs in Europe.
Mathé G, van Putten LM. Mathé G, et al. Cancer Chemother Pharmacol. 1978;1(1):5-13. doi: 10.1007/BF00253141. Cancer Chemother Pharmacol. 1978. PMID: 373907 Review. No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database